Primary Compound Sample Clauses

Primary Compound. Roche shall pay to Pharmasset the following nonrefundable payments (shown in [***]of US Dollars) upon the first occurrence of the following events for the Primary Compound: [***] [***] [***] [***] [***] [***]
View SourceView Similar (2)
Primary Compound. Roche shall pay to Pharmasset the following nonrefundable payments (shown in millions of US Dollars) upon the first occurrence of the following events for the Primary Compound: Initiation of Phase 1 MAD/POC Study 5.0 The earlier of (i) [***], or (ii) successful conclusion of the fourteen (14) day patient POC study for a Primary Compound (as defined in Schedule 2B and agreed upon by the JDMC) or (iii) [***] 7.5 [***] [***] Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets and asterisks [***], have been separately filed with the Commission.
View Source

Related to Primary Compound

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Combination Product The term “

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.